First Time Loading...
V

VIVA Biotech Holdings
HKEX:1873

Watchlist Manager
VIVA Biotech Holdings
HKEX:1873
Watchlist
Price: 0.61 HKD Market Closed
Updated: May 3, 2024

VIVA Biotech Holdings
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

VIVA Biotech Holdings
Operating Income Peer Comparison

Comparables:
603259
300759
2269
300347
M
688114

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
V
VIVA Biotech Holdings
HKEX:1873
Operating Income
¥211.1m
CAGR 3-Years
33%
CAGR 5-Years
31%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Operating Income
¥11.5B
CAGR 3-Years
52%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Operating Income
¥1.8B
CAGR 3-Years
18%
CAGR 5-Years
32%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Operating Income
¥4.4B
CAGR 3-Years
39%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Operating Income
¥1.7B
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
34%
M
MGI Tech Co Ltd
SSE:688114
Operating Income
¥190.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is VIVA Biotech Holdings's Operating Income?
Operating Income
211.1m CNY

Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Operating Income amounts to 211.1m CNY.

What is VIVA Biotech Holdings's Operating Income growth rate?
Operating Income CAGR 5Y
31%

Over the last year, the Operating Income growth was -29%. The average annual Operating Income growth rates for VIVA Biotech Holdings have been 33% over the past three years , 31% over the past five years .